Patents/Assignees

Beigene, Ltd.

13 patents in portfolio

US12582604utility2026
Stable Solid Dispersion of a B-RAF Kinase Dimer Inhibitor, Methods of Preparation, and Uses Therefor
0 cites
US12435104utility2025
Cyclic Dinucleotides as Sting Agonists
0 cites
US12286430utility2025
Bcl-2 Inhibitor
0 cites
US12281119utility2025
Imidazo[2,1-f][1,2,4]triazin-4-amine Derivatives as TLR7 Agonist
0 cites
US12195449utility2025
3-[(1h-pyrazol-r-yl)oxy]pyrazin-2-amine Compounds as HPK1 Inhibitor and Use Thereof
0 cites
US12103974utility2024
Anti-ox40 Antibodies and Methods of Use
0 cites
US12077536utility2024
BCL-2 Inhibitors
0 cites
US11905294utility2024
Imidazo[1,5-a]pyrazine Derivatives as Pi3kδ Inhibitors
0 cites
US11875885utility2024
Interoperable Platform for Reducing Redundancy in Medical Database Management
0 cites
US11725012utility2023
Imidazo[1,5-a]pyrazine Derivatives as PI3K Δ Inhibitors
0 cites
US11636930utility2023
Interoperable Platform for Reducing Redundancy in Medical Database Management
0 cites
US11597768utility2023
Immunotherapy for Hepatocellular Carcinoma
0 cites
US11555038utility2023
Crystalline Forms of (s)-7-(1-(but-2-ynoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide, Preparation, and Uses Thereof
0 cites